Cadent Therapeutics
United States
unknown
unknown
Stage
1
Investors
About
Cadent Therapeutics is a biotechnology company focused on developing therapies to treat neurological and neuropsychiatric disorders by targeting neurons controlling brain circuits.
Explore Cadent Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.